
Last updated: 3 months ago
Vertex Pharmaceuticals Q4 2024 Financial Report: Growth Amidst Challenges
Explore Vertex Pharmaceuticals' Q4 2024 financial report revealing $11B in revenue, but a net loss of $536M. Key insights on R&D spending and market position.